Gynecologic Oncology Group Trials

The Gynecologic Oncology Group (GOG) is a non-profit organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. The Group is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. Continuous evaluation of its processes is utilized in order to constantly improve the quality of patient care. To promote this mission, the GOG receives support from the National Cancer Institute (NCI) of the National Institutes for Health (NIH).

Approximately 45 individual clinical trials are active at any one time within GOG for patients with a variety of gynecologic malignancies, including cancers that arise from the ovaries, uterus, cervix, vagina, and vulva. GOG partners with the Foundation for Women’s Cancer to promote clinical trials participation and provide easy-to-access information about clinical trials that currently are open for enrollment.

View the list of GOG Clinical Trials.

Additional Clinical Trial Resources

Spotlight

SGO, ASCCP Clarify Recommendations of Primary HPV Testing for Cervical Cancer Screening. Read the release.

Awareness

We’re pleased to partner with the Dana Farber Cancer Institute to promote their recent webchat on cervical cancer treatment - watch now!

Research

The Foundation’s research award winners will be notified in January. Thank you to all who sent in their applications.

Education

The next Gynecologic Cancer Survivors Course is February 7-8 in Anchorage, Alaska. For more information, click here.